Locations:

Pulmonary

18-PUL-4761-Chaisson-Hero-Image-650x450pxl

November 27, 2018/Primary Care

Evaluating WHO Group 5 Pulmonary Hypertension and Prognostic Risk Stratification

PH due to miscellaneous causes

18-PUL-4530-Hatipoglu-Hero-Image-650x450pxl_02

November 19, 2018/Pulmonary/Research

Electronic Inhaler Monitoring at the Respiratory Institute

Benefits could extend to patients with COPD

November 12, 2018/Pulmonary/Allergy & Immunology

Omalizumab Can Block Aspirin-Provoked Respiratory Reaction During Aspirin Desensitization

Mechanism likely related to reduced capacity for release of leukotrienes

Chronic Thromboembolic Pulmoary Hypertension Program

November 6, 2018/Primary Care

Evaluating Suspected Pulmonary Hypertension, WHO Group 4

CTEPH: A diagnostic approach

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

October 25, 2018/Pulmonary/Research

Unanswered Questions in Treatment-Resistant Pulmonary Sarcoidosis

Research needed to fill critical knowledge gaps

October 18, 2018/Primary Care

Evaluating Suspected Pulmonary Hypertension, WHO Group 3

A diagnostic approach

18-PUL-4758-Chaisson-Hero-Image-650x450pxl

October 8, 2018/Primary Care

Evaluating Suspected Pulmonary Hypertension Due to Left Heart Disease

A diagnostic approach

18-PUL-4645-Tolle-Hero-Image-650x450pxl[5]

September 26, 2018/Pulmonary/Interstitial Lung Disease

How to Treat Idiopathic Pulmonary Fibrosis

An overview of available treatment modalities

September 20, 2018/Primary Care

Evaluating Suspected Pulmonary Hypertension: A Structured Approach

A diagnostic approach

18-PUL-4644-Tolle-Hero-Image-650x450pxl_02

September 12, 2018/Primary Care

A Diagnostic Algorithm for Idiopathic Pulmonary Fibrosis

When primary care physicians should suspect IPF

BackPage 24 of 37Next